Rwanda vs Uganda: Population requiring preventive chemotherapy for schistosomiasis
Rwanda
5.47 million
in 2024
Uganda
7.98 million
in 2024
Rwanda rank
14th
Uganda rank
11th
Population requiring preventive chemotherapy for schistosomiasis over time
- Rwanda
- Uganda
How they compare
Uganda currently reports 7.98 million against 5.47 million in Rwanda, a difference of 2.51 million.
That makes Uganda's figure about 1.5 times Rwanda's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Uganda ahead.
Rwanda ranks 14th and Uganda ranks 11th of 52 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.64 million | 10.07 million | 8.43 million | Uganda |
| 2020s | 4.32 million | 9.71 million | 5.39 million | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Rwanda or Uganda?
- Uganda, at 7.98 million against 5.47 million in Rwanda as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Rwanda and Uganda?
- 2.51 million, with Uganda ahead.
- How many years of comparable data are there for Rwanda and Uganda?
- 15 years are reported by both, from 2010 to 2024.
- How do Rwanda and Uganda rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Rwanda ranks 14th and Uganda ranks 11th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.